National Drug Intelligence Center |
This assessment is an outgrowth of a partnership between the NDIC and HIDTA Program for preparation of annual assessments depicting drug trafficking trends and developments in HIDTA Program areas. The report has been coordinated with the HIDTA, is limited in scope to HIDTA jurisdictional boundaries, and draws upon a wide variety of sources within those boundaries.
Your questions, comments, and suggestions for future subjects are welcome at any time. Addresses are provided at the end of the page.
Cover photo: ©EyeWire, Inc.™
Major Drug Markets
Portland
Market Overview
Production
Transportation
Distribution
Abuse
Salem
Market Overview
Production
Transportation
Distribution
Abuse
Roseburg/Medford/Pendleton
Market Overview
Figure 1. Oregon High Intensity Drug
Trafficking Area.
Figure 2.
Cannabis Plants Seized From HIDTA Counties, 2005-2007
Figure 3.
Methamphetamine Laboratories Seized in HIDTA Counties, 2005-2007
Figure 4.
Methamphetamine Laboratories Seized in Clackamas, Multnomah, and
Washington Counties, 2005-2007
Figure 5.
Indoor Cannabis Plant Seizures in HIDTA Counties, 2007
Figure 6.
Drug-Related Deaths in HIDTA Counties, 2007
Figure 7.
Treatment Admissions for Clackamas, Multnomah, and Washington
Counties, 2005-2007
Figure 8.
Methamphetamine Laboratories Seized in Marion County, 2005-2007
Figure 9.
Treatment Admissions for Marion County, 2005-2007
Figure 10.
Methamphetamine Laboratories Seized in Douglas, Jackson, and
Umatilla Counties, 2005-2007
Figure 11.
Treatment Admissions for Douglas, Jackson, and Umatilla Counties,
2005-2007
Table 1. Oregon HIDTA Retail Distributors by Drug
This assessment provides a strategic overview of the illicit drug situation in the Oregon High Intensity Drug Trafficking Area (HIDTA), highlighting significant trends and law enforcement concerns related to the trafficking and abuse of illicit drugs. The report was prepared through detailed analysis of recent law enforcement reporting, information obtained through interviews with law enforcement and public health officials, and available statistical data. The report is designed to provide policymakers, resource planners, and law enforcement officials with a focused discussion of key drug issues and developments facing the Oregon HIDTA.
National Drug Intelligence Center
319 Washington Street, 5th Floor
Johnstown, PA 15901-1622
Tel. (814) 532-4601
FAX (814) 532-4690
E-mail NDIC.Contacts@usdoj.gov
National Drug Intelligence Center
United States Department of Justice
Robert F. Kennedy Building (Room 1335)
950 Pennsylvania Avenue NW
Washington, DC 20530
Tel. (202) 432-4040
FAX (202) 514-4252
ADNET: http://ndicosa
DOJ: http://www.usdoj.gov/ndic/
LEO: https://www.leo.gov/http/leowcs.leopriv.gov/lesig/ndic/index.htm
RISS: ndic.riss.net
To Top To Contents To Next Page
To Publications Page To Home Page
End of page.